Advertisement
Advances in Pediatrics

Trends in Pediatric Recreational Drug Use and Ingestions

      Adolescent recreational and polysubstance drug use are widespread, substances are easily accessible, and current popular drugs used are constantly evolving.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Centers for Disease Control and Prevention
        • National Center for Injury Prevention and Control
        Vital signs: unintentional injury deaths among persons aged 0–19 years—United States, 2000–2009.
        MMWR Morb Mortal Wkly Rep. 2012; 61: 270-276
        • Valdez A.
        • Mars T.
        Rx for injury: adolescent prescription drug misuse.
        J Emerg Nurs. 2014; 40: 497-499
        • Burghardt L.
        • Ayers J.
        • Brownstein J.
        • et al.
        Adult prescription drug use and pediatric medication exposures and poisonings.
        J Pediatr. 2013; 132: 18-27
        • National Survey of Drug Use and Health
        National Institute on Drug Abuse.
        (Available at:) (Accessed August 5, 2020)
        • Weinberg N.
        • Lopez M.
        • Compton W.
        Epidemiology of drug abuse: building blocks for etiologic research.
        in: Madras B. Kuhar M. The effects of drug abuse on the human nervous system. Elsevier, Oxford (United Kingdom)2014: 51-76
        • Dube S.
        • Felitti V.
        • Dong M.
        • et al.
        Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the Adverse Childhood Experiences Study.
        J Pediatr. 2003; 111: 564-572
        • Stein M.
        • Conti M.
        • Kenney S.
        • et al.
        Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder.
        Drug Alcohol Depend. 2017; 179: 325-329
        • Allem J.
        • Soto D.
        • Baezconde-Garbanati L.
        • et al.
        Adverse childhood experiences and substance use among Hispanic emerging adults in Southern California.
        Addict Behav. 2015; 50: 199-204
        • Dube S.
        • Miller J.
        • Brown D.
        • et al.
        Adverse childhood experiences and the association with ever using alcohol and initiating alcohol use during adolescence.
        J Adolesc Health. 2006; 38: 1-10
        • Anda R.
        • Croft J.
        • Felitti V.
        • et al.
        Adverse childhood experiences and smoking during adolescence and adulthood.
        JAMA. 1999; 282: 1652-1658
        • LeTendre M.
        • Reed M.
        The effect of adverse childhood experience on clinical diagnosis of a substance use disorder: results of a nationally representative study.
        Subst Use Misuse. 2017; 52: 689-697
        • McGue M.
        • Iacono W.
        The adolescent origins of substance use disorders.
        Int J Methods Psychiatr Res. 2008; 17: 30-38
        • Timberlake D.
        • Haberstick B.
        • Hopfer C.
        • et al.
        Progression from marijuana use to daily smoking and nicotine dependence in a national sample of U.S. adolescents.
        Drug Alcohol Depend. 2007; 88: 272-281
        • Palmer R.
        • Young S.
        • Hopfer C.
        • et al.
        Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk.
        Drug Alcohol Depend. 2009; 102: 78-87
      1. Gummin D, Mowry J, Spyker D, et al. 2018 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th annual report. Clin Toxicol (Phila) 2019;57(12):1220-1413.

        • Cullen K.
        • Gentzke A.
        • Sawdey M.
        • et al.
        e-Cigarette use among youth in the United States, 2019.
        JAMA. 2019; 322: 2095-2103
        • Hamberger E.
        • Halpern-Felsher B.
        Vaping in adolescents: epidemiology and respiratory harm.
        Curr Opin Pediatr. 2020; 32: 378-383
        • Miech R.
        • Johnston L.
        • O'Malley P.M.
        • et al.
        Trends in adolescent vaping, 2017-2019.
        N Engl J Med. 2019; 381: 1490-1491
        • Spindle T.
        • Hiler M.
        • Cooke M.
        • et al.
        Electronic cigarette use and uptake of cigarette smoking: a longitudinal examination of U.S. College Students.
        Addict Behav. 2017; 67: 66-72
        • Wills T.
        • Knight R.
        • Sargent J.
        • et al.
        Longitudinal study of e-cigarette use and onset of cigarette smoking among high school students in Hawaii.
        Tob Control. 2017; 26: 34-39
        • Miech R.
        • Patrick M.
        • O'Malley P.
        • et al.
        E-cigarette use as a predictor of cigarette smoking: results from a 1-year follow-up of a national sample of 12th grade students.
        Tob Control. 2017; 26: 106-111
        • Goldenson N.
        • Leventhal A.
        • Stone M.
        • et al.
        Associations of electronic cigarette nicotine concentration with subsequent cigarette smoking and vaping levels in adolescents.
        JAMA Pediatr. 2017; 171: 1192-1199
        • Mishra A.
        • Chaturvedi P.
        • Datta S.
        • et al.
        Harmful effects of nicotine.
        Indian J Med Paediatr Oncol. 2015; 36: 24-31
        • Layden J.
        • Ghinai I.
        • Pray I.
        • et al.
        Pulmonary illness related to E-Cigarette use in Illinois and Wisconsin - Final report.
        N Engl J Med. 2020; 382: 903-916
        • Messina M.
        • Levin T.
        • Conrad L.
        • et al.
        Vaping associated lung injury: a potentially life-threatening epidemic in US youth.
        Pediatr Pulmonol. 2020; 55: 1705-1711
        • Wang K.
        • Jadhav S.
        • Smitha Yenduri N.
        • et al.
        E-cigarette or vaping product use-associated lung injury in the pediatric population: imaging features at presentation and short-term follow-up.
        Pediatr Radiol. 2020; 50: 1231-1239
        • Khanijo S.
        • Lou B.
        • Makaryus M.
        • et al.
        Coagulopathy and inflammatory dysregulation with E-Cigarette use.
        Am J Med. 2020; 133: 530-531
        • Maddock S.
        • Cirulis M.
        • Callahan S.
        • et al.
        Pulmonary lipid-laden macrophages and vaping.
        N Engl J Med. 2019; 381: 1488-1489
        • Triantafyllou G.
        • Tiberio P.
        • Zou R.
        • et al.
        Vaping-associated acute lung injury: a case series.
        Am J Respir Crit Care Med. 2019; 200: 1430-1431
        • Beck E.
        • Taylor R.
        • Lee L.
        • et al.
        Bronchoconstriction and apnea induced by cigarette smoke: nicotine dose dependence.
        Lung. 1986; 164: 293-301
        • Corcoran A.
        • Carl J.
        • Rezaee F.
        The importance of anti-vaping vigilance-EVALI in seven adolescent pediatric patients in Northeast Ohio.
        Pediatr Pulmonol. 2020; 55: 1719-1724
        • Carroll B.
        • Kim M.
        • Hemyari A.
        • et al.
        Impaired lung function following e-cigarette or vaping product use associated lung injury in the first cohort of hospitalized adolescents.
        Pediatr Pulmonol. 2020; 55: 1712-1718
        • Bhatta D.
        • Glantz S.
        Association of E-cigarette use with respiratory disease among adults: a longitudinal analysis.
        Am J Prev Med. 2019; 58: 182-190
        • Wong K.
        • Baum C.
        Acute Cannabis Toxicity.
        Pediatr Emerg Care. 2019; 35: 799-804
      2. “Legality of Cannabis by U.S. Jurisdiction.” Wikipedia, Wikimedia Foundation.
        (Available at:) (Accessed November 18, 2020)
        • Blohm E.
        • Sell P.
        • Neavyn M.
        Cannabinoid toxicity in pediatrics.
        Curr Opin Pediatr. 2019; 31: 256-261
        • Dirisu O.
        • Shickle D.
        • Elsey H.
        Influence of legal status on the uptake of cannabis in young people.
        Curr Opin Psychiatry. 2016; 29: 231-235
        • Richards J.
        • Smith N.
        • Moulin A.
        Unintentional Cannabis ingestion in children: a systematic review.
        J Pediatr. 2017; 190: 142-152
        • Richards J.
        • Gordon B.
        • Danielson A.
        • et al.
        Pharmacologic treatment of Cannabinoid hyperemesis syndrome: a systematic review.
        Pharmacotherapy. 2017; 37: 725-734
        • Sorensen C.
        • DeSanto K.
        • Borgelt L.
        • et al.
        Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment-a systematic review.
        J Med Toxicol. 2017; 13: 71-87
        • Ryan S.
        • Ammerman S.
        • Committee on Substance Use and Prevention
        Counseling parents and teens about Marijuana use in the era of legalization of Marijuana.
        J Pediatr. 2017; 139: e20164069
        • Aldy K.
        • Cao D.
        • Weaver M.
        • et al.
        E-cigarette or vaping product use-associated lung injury (EVALI) features and recognition in the emergency department.
        J Am Coll Emerg Physicians Open. 2020; 1: 1090-1096
        • Gilley M.
        • Brent J.
        • Calello D.
        • et al.
        • Toxicology Investigators Consortium
        Synthetic cannabinoid exposure in adolescents presenting for emergency care.
        Pediatr Emerg Care. 2021; 37: 13-16
        • Katz K.
        • Leonetti A.
        • Bailey B.
        • et al.
        Case series of synthetic cannabinoid intoxication from one toxicology center.
        West J Emerg Med. 2016; 17: 290-294
        • Kourouni I.
        • Mourad B.
        • Khouli H.
        • et al.
        Critical illness secondary to synthetic cannabinoid ingestion.
        JAMA Netw Open. 2020; 3: 1-11
        • Dharmapuri S.
        • Miller K.
        • Klein J.
        Marijuana and the pediatric population.
        J Pediatr. 2020; 146: 279-289
        • Foster B.C.
        • Abramovici H.
        • Harris C.S.
        Cannabis and cannabinoids: kinetics and interactions.
        Am J Med. 2019; 132: 1266-1270
        • Ninnemann A.
        • Choi H.J.
        • Stuart G.
        • et al.
        Longitudinal predictors of synthetic cannabinoid use in adolescents.
        J Pediatr. 2017; 139: 1-7
        • Keyes K.
        • Rutherford C.
        • Hamilton A.
        • et al.
        Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.
        Drug Alcohol Depend. 2016; 166: 159-167
        • Clayton H.
        • Lowry R.
        • Ashley C.
        • et al.
        Health risk behaviors with synthetics cannabinoids versus marijuana.
        J Pediatr. 2017; 139: 1-10
        • Palamar J.
        • Barratt M.
        • Coney L.
        • et al.
        Synthetic cannabinoid use among high school seniors.
        J Pediatr. 2017; 140: 1-9
        • Kelly B.
        • Nappe T.
        Cannabinoid toxicity.
        StatPearls Publishing, Treasure Island (FL)2020
        • Anderson S.A.
        • Oprescu A.
        • Calello D.
        • et al.
        Neuropsychiatric sequelae in adolescents with acute synthetic cannabinoid toxicity.
        J Pediatr. 2019; 144: 1-7
        • Cohen J.
        • Morrison S.
        • Greenberg J.
        • et al.
        Clinical presentation of intoxication due to synthetic cannabinoids.
        J Pediatr. 2012; 129: 1064-1067
        • Mir A.
        • Obafemi A.
        • Young A.
        • et al.
        Myocardial infarction associated with use of the synthetic cannabinoid K2.
        J Pediatr. 2011; 128: 1622-1627
        • Rubino T.
        • Realini N.
        • Braida D.
        • et al.
        Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood.
        Hippocampus. 2009; 19: 763-772
        • Zosel A.
        • Bartelson B.
        • Bailey E.
        • et al.
        Characterization of adolescent prescription drug abuse and misuse using the researched abuse diversion and addiction-related surveillance (RADARS) system.
        J Am Acad Child Adolesc Psychiatry. 2013; 52: 196-204
        • McCabe S.
        • West B.
        • Teter C.
        • et al.
        Medical and nonmedical use of prescription opioids among high school seniors in the United States.
        Arch Pediatr Adolesc Med. 2012; 166: 797-802
        • Gaither J.
        • Shabanova V.
        • Leventhal J.
        US national trends in pediatric deaths from prescription and illicit opioids.
        JAMA Netw Open. 2018; 1: e186558
        • Gugelmann H.
        • Nelson L.
        The prescription opioid epidemic: repercussions on pediatric emergency medicine.
        Clin Pediatr Emerg Med. 2012; 13: 260-268
        • Strassels S.
        Economic burden of prescription opioid misuse and abuse.
        J Manag Care Spec Pharm. 2009; 15: 556-562
        • Spehr M.
        • Coddington J.
        • Ahmed A.
        • et al.
        Parental opioid abuse: barriers to care, policy, and implications for primary care pediatric providers.
        J Pediatr Health Care. 2017; 31: 695-702
        • Smith V.
        • Wilson C.
        Families affected by parental substance use.
        J Pediatr. 2016; 138: 1-13
        • Child Welfare Information Gateway
        Parental substance use and the child welfare system.
        Children’s Bureau, Washington, DC2014 (Available at:) (Accessed September 10, 2020)
        • Mazer-Amirshahi M.
        • Mullins P.
        • Rasooly I.
        • et al.
        Trends in prescription opioid use in pediatric emergency department patients.
        Pediatr Emerg Care. 2014; 30: 230-235
        • Horton J.
        • Munawar S.
        • Corrigan C.
        • et al.
        Inconsistent and excessive opioid prescribing after common pediatric surgical operations.
        J Pediatr Surg. 2019; 54: 1427-1431
        • Anderson K.
        • Bartz-Kurycki M.
        • Ferguson D.
        • et al.
        Too much of a bad thing: discharge opioid prescriptions in pediatric appendectomy patients.
        J Pediatr Surg. 2018; 53: 2374-2377
        • Harbaugh C.
        • Lee J.
        • Hu H.
        • et al.
        Persistent opioid use among pediatric patients after surgery.
        J Pediatr. 2018; 141: e20172439
        • Hill M.V.
        • Mcmahon M.L.
        • Stucke R.S.
        • et al.
        Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures.
        Ann Surg. 2017; 265: 709-714
        • Allen J.
        • Casavant M.
        • Spiller H.
        • et al.
        Prescription opioid exposures among children and adolescents in the United States: 2000–2015.
        J Pediatr. 2017; 139: e20163382
        • Tadros A.
        • Layman S.
        • Davis S.
        • et al.
        Emergency department visits by pediatric patients for poisoning by prescription opioids.
        Am J Drug Alcohol Abuse. 2016; 42: 550-555
        • Committee on Drugs
        Naloxone dosage and route of administration for infants and children: addendum to emergency drug doses for infants and children.
        J Pediatr. 1990; 86: 484-485
        • Chamberlain J.
        • Klein B.
        A comprehensive review of naloxone for the emergency physician.
        Am J Emerg Med. 1994; 12: 650-660
        • Goldfrank L.
        • Weisman R.
        • Errick J.
        • et al.
        A dosing nomogram for continuous infusion intravenous naloxone.
        Ann Emerg Med. 1986; 15: 566-570
      3. Lovegrove M, Hampton LM, Budnitz DS, et al. Notes from the Field: Emergency Department Visits and Hospitalizations for Buprenorphine Ingestion by Children — United States, 2010–2011. Morbidity and Mortality Weekly Report (MMWR). Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/%20mm6203a5.htm.

        • Pedapati E.
        • Bateman S.
        Toddlers requiring pediatric intensive care unit admission following at-home exposure to buprenorphine/naloxone.
        Pediatr Crit Care Med. 2011; 12: 102-107
        • Solecki S.
        • Turchi R.
        Pharming: pill parties can be deadly for teens.
        Contemp Pediatr. 2014; 31: 24-27
        • Simmons L.
        • Havens J.
        • Whiting J.
        • et al.
        Illicit drug use among women with children in the United States 2002-2003.
        Ann Epidemiol. 2009; 19: 187-193
        • Patrick S.
        • Schumacher R.
        • Benneyworth B.
        • et al.
        Neonatal abstinence syndrome and associated health care expenditures.
        JAMA. 2012; 307: 1934-1940
        • McGlone L.
        • Mactier H.
        Infants of opioid-dependent mothers: neurodevelopment at six months.
        Early Hum Dev. 2014; 91: 19-21
        • McHugh R.K.
        • Nielsen S.
        • Weiss R.
        Prescription drug abuse: from epidemiology to public policy.
        J Subst Abuse Treat. 2015; 48: 1-7
        • Howard M.
        • Weiler R.
        • Haddox J.
        Development and reliability of items measuring the nonmedical use of prescription drugs for the Youth Risk Behavior Survey: results from an initial pilot test.
        J Sch Health. 2009; 79: 554-560
        • Warner M.
        • Chen L.
        • Makuc D.
        • et al.
        Drug poisoning deaths in the United States, 1980–2008. NCHS data brief, No. 81.
        National Center for Health Statistics, Hyattsville (MD)2011 (Available at:)
        • Whiteside L.
        • Walton M.
        • Bohnert A.
        • et al.
        Nonmedical prescription opioid and sedative use among adolescents in the emergency department.
        J Pediatr. 2013; 132: 825-832
        • Schepis T.
        • Teter C.
        • McCabe S.
        Prescription drug use, misuse and related substance use disorder symptoms vary by educational status and attainment in US adolescents and young adults.
        Drug Alcohol Depend. 2018; 189: 172-177
        • Johnston L.
        • O’Malley P.
        • Bachman J.
        • et al.
        Monitoring the Future national survey results on drug use, 195-2006. Volume II: college students and adults ages 19-45. NIH Publication 07-6206.
        National Institute on Drug Abuse, Bethesda (MD)2007
        • Huang D.
        • Dawson D.
        • Stinson F.
        • et al.
        Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on Alcohol and related conditions.
        J Clin Psychiatry. 2006; 67: 1062-1073
        • Boyd C.
        • McCabe S.
        • Cranford J.
        • et al.
        Adolescents’ motivations to abuse prescription medications.
        J Pediatr. 2006; 118: 2472-2480
        • Taylor O.
        The cultural influence of adolescent prescription drug abuse.
        Hum Behav Macro Social Environ. 2015; 25: 304-311
        • Joffe A.
        Your role in curbing prescription and OTC drug abuse by adolescents.
        Contemp Pediatr. 2006; 23: 97-101
        • Katsuki T.
        • Mackey T.
        • Cuomo R.
        Establishing a link between prescription drug abuse and illicit online pharmacies: analysis of Twitter data.
        J Med Internet Res. 2015; 17: e280
        • Levine D.
        ‘Pharming’: the abuse of prescription and over-the-counter drugs in teens.
        Curr Opin Pediatr. 2007; 19: 270-274
        • Elliott E.
        • Souder C.
        • Privette T.
        • et al.
        The scope of adolescent prescription drug abuse.
        Emerg Med. 2009; 41: 16-22
        • Schepis T.
        • Krishnan-Sarin S.
        Characterizing adolescent prescription misusers: a population-based study.
        J Am Acad Child Adolesc Psychiatry. 2008; 47: 745-754
        • Jones B.
        • Fullwood H.
        • Hawthorn M.
        Preventing prescription drug abuse in adolescence: a collaborative approach.
        Prev Res. 2012; 19: 13-16
        • Caplan J.
        • Epstein L.
        • Quinn D.
        • et al.
        Neuropsychiatric effects of prescription drug abuse.
        Neuropsychol Rev. 2007; 17: 363-380
        • Drazdowski T.
        • Jaggi L.
        • Borre A.
        • et al.
        Use of prescription drugs and future delinquency among adolescent offenders.
        J Subst Abuse Treat. 2015; 48: 28-36
        • Bornemann J.
        The viability of microdosing psychedelics as a strategy to enhance cognition and well-being - an early review.
        J Psychoactive Drugs. 2020; 52: 300-308
        • Johnstad P.
        Powerful substances in tiny amounts: an interview study of psychedelic microdosing.
        Nordisk Alkohol Nark. 2018; 35: 39-51
        • Kuypers K.
        • Ng L.
        • Erritzoe D.
        • et al.
        Microdosing psychedelics: more questions than answers? An overview and suggestions for future research.
        J Psychopharmacol. 2019; 33: 1039-1057
        • Lea T.
        • Amada N.
        • Jungaberle H.
        • et al.
        Microdosing psychedelics: motivations, subjective effects and harm reduction.
        Int J Drug Policy. 2020; 75: 102600
        • Fadiman J.
        • Korb S.
        Might microdosing psychedelics be safe and beneficial? An initial exploration.
        J Psychoactive Drugs. 2019; 51: 118-122
        • Leonard J.
        • Anderson B.
        • Klein-Schwartz W.
        Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.
        J Pschopharmacol. 2018; 32: 1286-1294
        • Ni A.
        • Cantrell L.
        • Clark R.
        Ketamine exposure demographics and outcome over 16 years as reported to US poison centers.
        Am J Emerg Med. 2018; 36: 1459-1462
        • Degenhardt L.
        • Copeland J.
        • Dillon P.
        Recent trends in the use of “club drugs”: an Australian review.
        Subst Use Misuse. 2005; 40: 1241-1256
        • Schwartz R.
        LSD: its rise, fall, and renewed popularity among high school students.
        Pediatr Clin North Am. 1995; 42: 403-412
        • Weiner A.
        • Vieira L.
        • McKay C.
        • et al.
        Ketamine abusers presenting to the emergency department: a case series.
        J Emerg Med. 2000; 18: 447-451
        • Bearn J.
        • O’Brien M.
        “Addicted to Euphoria”: the history, clinical presentation, and management of party drug misuse.
        Int Rev Neurobiol. 2015; 120: 205-233
        • Copeland J.
        • Dillon P.
        The health and psycho-social consequences of ketamine use.
        Int J Drug Policy. 2005; 16: 122-131
        • Kalsi S.
        • Wood D.
        • Dargan P.
        The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use.
        Emerg Health Threats J. 2011; 4: 7107-7116
        • Williams J.
        • Storck M.
        • Committee on Substance Abuse and Committee on Native American Child Health
        Inhalant abuse.
        J Pediatr. 2007; 119: 1009-1017
        • Wu L.
        • Pilowsky D.
        • Schlenger W.
        • et al.
        Inhalant abuse and dependence among adolescents in the United States.
        J Am Acad Child Adolesc Psychiatry. 2004; 43: 1206-1214
        • McGarvey E.
        • Clavet G.
        • Mason W.
        • et al.
        Adolescent inhalant abuse: environments of use.
        Am J Drug Alcohol Abuse. 1999; 25: 731-741
        • Kurtzman R.
        • Otsuka K.
        • Wahl R.
        Inhalant abuse by adolescents.
        J Adolesc Health. 2001; 28: 170-180
        • Forrester M.
        Computer and electronic duster spray inhalation (huffing) injuries managed at emergency departments.
        Am J Drug Alcohol Abuse. 2020; 46: 180-183
        • Cazzell M.
        Linking theory, evidence, and practice in assessment of adolescent inhalant use.
        J Addict Nurs. 2008; 19: 17-25
        • Nguyen J.
        • O’Brien C.
        • Schapp S.
        • et al.
        Adolescent inhalant use prevention, assessment, and treatment: a literature synthesis.
        Int J Drug Policy. 2016; 31: 15-24
        • Johnston L.
        • O'Malley P.
        • Bachman J.
        • et al.
        Monitoring the future national survey results on drug use, 1975–2008. Volume I: secondary school students (NIH Publication No. 09–7402).
        National Institute on Drug Abuse, Bethesda (MD)2009
        • Anderson C.
        • Loomis G.
        Recognition and prevention of inhalant abuse.
        Am Fam Physician. 2003; 68: 869-874
        • Nonnemaker J.
        • Crankshaw E.
        • Shive D.
        • et al.
        Inhalant use initiation among US adolescents: evidence from the National Survey of Parents and Youth using discrete-time survival analysis.
        Addict Behav. 2011; 36: 878-881
        • Crossin R.
        • Cairney S.
        • Lawrence A.
        • et al.
        Adolescent inhalation abuse leads to other drug use and impaired growth; implications for diagnosis.
        Aust N Z J Public Health. 2017; 41: 99-104
        • Howard M.
        • Bowen S.
        • Garland E.
        • et al.
        Inhalant use and inhalant use disorders in the United States.
        Addict Sci Clin Pract. 2011; 6: 18-31
        • Plumb J.
        • Thomas R.
        Sudden severe perioral swelling in an adolescent boy.
        Clin Toxicol. 2013; 51: 379-380
        • Mermiri D.
        • Papdopoulou A.
        • Xristianakis E.
        • et al.
        Severe lung injury due to chronic volatile hydrocarbon (VHC) inhalation in an adolescent.
        Eur Respir J. 2016; 48: PA3914
        • Baird C.
        • Furek M.
        Adolescents and inhalant abuse: how huffing affects the myelin sheath.
        J Addict Nurs. 2012; 23: 129-131
        • Wilson M.
        • Ferguson R.
        • Mazer M.
        • et al.
        Monitoring trends in dextromethorphan abuse using the National Poison Data System: 2000–2010.
        Clin Toxicol. 2011; 49: 409-415
        • Karami S.
        • Major J.
        • Calderon S.
        • et al.
        Trends in dextromethorphan cough and cold products: 2000-2015 National Poison Data System intentional abuse exposure calls.
        Clin Toxicol. 2018; 56: 656-663
        • Consumer Healthcare Products Association
        Dextromethorphan: preventing teen cough medicine abuse.
        Consumer Healthcare Products Association, Washington, DC2017 (Available at:) (Accessed 10 November 2020)
        • Falck R.
        • Li L.
        • Carlson R.
        • et al.
        The prevalence of dextromethorphan abuse among high school students.
        J Pediatr. 2006; 118: 2267-2269
        • Akerman S.
        • Hammel J.
        • Brunette M.
        Dextromethorphan abuse and dependence in adolescents.
        J Dual Diagn. 2010; 6: 266-278
        • Silvasti M.
        • Karttunen P.
        • Tukiainen H.
        • et al.
        Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers.
        Int J Clin Pharmacol Ther Toxicol. 1987; 25: 493-497
        • Romanelli F.
        • Smith K.
        Dextromethorphan abuse: clinical effects and management.
        J Am Pharm Assoc. 2009; 49: 20-27
        • Antoniou T.
        • Juurlink D.
        Dextromethorphan abuse.
        CMAJ. 2014; 186: E631
        • Boyer E.
        Dextromethorphan abuse.
        Pediatr Emerg Care. 2004; 20: 858-863
        • Schwartz R.
        Adolescent abuse of dextromethorphan.
        Clin Pediatr. 2005; 44: 565-568
        • Helfer J.
        • Kim O.
        Psychoactive abuse potential of Robitussin-DM.
        Am J Psychiatry. 1990; 147: 672-673
        • Ziaee V.
        • Hamed E.
        • Hoshmand A.
        • et al.
        Side effects of dextromethorphan abuse, a case series.
        Addict Behav. 2005; 30: 1607-1613